HIV-HBV coinfection - A global challenge

New England Journal of Medicine

Volumn 366, Issue 19, 2012, Pages 1749-1752

  Kourtis, Athena P ^a   Bulterys, Marc ^b,c   Hu, Dale J ^b   Jamieson, Denise J ^a  

^a NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c CDC Global AIDS Program   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B VACCINE; TENOFOVIR;

CAUSE OF DEATH; CHRONIC LIVER DISEASE; DISEASE ASSOCIATION; DISEASE EXACERBATION; HEPATITIS B; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION CONTROL; INFECTION PREVENTION; INFECTION RATE; INFECTION RISK; MIXED INFECTION; PATIENT EDUCATION; PREGNANCY OUTCOME; PRIORITY JOURNAL; RISK FACTOR; RISK REDUCTION; SHORT SURVEY; VIRUS TRANSMISSION;

EID: 84860744407     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMp1201796     Document Type: Article

References (5)

1. Hoffmann CJ, Thio CL. Clinical implications of HIV and hepatitis B co-infection in Asia and Africa. Lancet Infect Dis 2007; 7:402-9. (Pubitemid 46765200)
2. Thio CL. Hepatitis B and human immunodeficiency virus coinfection. Hepatology 2009;49:Suppl:S138-S145.
3. Xu WM, Cui YT, Wang L, et al. Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus infection: a multicentre, randomized, double-blind, placebocontrolled study. J Viral Hepat 2009;16: 94-103.
4. Unal ER, Lazenby GB, Lintzenich AE, Simpson KN, Newman R, Goetzl L. Cost-effectiveness of maternal treatment to prevent perinatal hepatitis B virus transmission. Obstet Gynecol 2011;118:655-62.
5. Kourtis AP, Bulterys M, Nesheim SL, Lee FK. Understanding the timing of HIV transmission from mother to infant. JAMA 2001; 285:709-12. (Pubitemid 32167219)